These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37491788)

  • 1. Anticholinergic Versus Antihistaminic Treatment for Simulator Sickness Prevention.
    Ben-Ari O; Sarfati S; Gordon B; Assa A; Nakdimon I
    J Clin Pharmacol; 2023 Oct; 63(10):1119-1125. PubMed ID: 37491788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of cinnarizine and cocculus indicus on simulator sickness.
    Lucertini M; Mirante N; Casagrande M; Trivelloni P; Lugli V
    Physiol Behav; 2007 May; 91(1):180-90. PubMed ID: 17434541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the efficacy of cinnarizine with scopolamine in the treatment of seasickness.
    Pingree BJ; Pethybridge RJ
    Aviat Space Environ Med; 1994 Jul; 65(7):597-605. PubMed ID: 7945125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scopolamine (hyoscine) for preventing and treating motion sickness.
    Spinks A; Wasiak J
    Cochrane Database Syst Rev; 2011 Jun; 2011(6):CD002851. PubMed ID: 21678338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scopolamine (hyoscine) for preventing and treating motion sickness.
    Spinks AB; Wasiak J; Villanueva EV; Bernath V
    Cochrane Database Syst Rev; 2007 Jul; (3):CD002851. PubMed ID: 17636710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scopolamine for preventing and treating motion sickness.
    Spinks AB; Wasiak J; Villanueva EV; Bernath V
    Cochrane Database Syst Rev; 2004; (3):CD002851. PubMed ID: 15266468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Simulator sickness and its measurement with Simulator Sickness Questionnaire (SSQ)].
    Biernacki MP; Kennedy RS; Dziuda Ł
    Med Pr; 2016; 67(4):545-55. PubMed ID: 27623835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postural Control and Psychophysical State Following of Flight Simulator Session in Novice Pilots.
    Polak E; Ślugaj R; Gardzińska A
    Front Public Health; 2022; 10():788612. PubMed ID: 35186837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of low-dose intranasal scopolamine for motion sickness.
    Simmons RG; Phillips JB; Lojewski RA; Wang Z; Boyd JL; Putcha L
    Aviat Space Environ Med; 2010 Apr; 81(4):405-12. PubMed ID: 20377145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scopolamine Treatment and Adaptation to Airsickness.
    Doron O; Samuel O; Karfunkel-Doron D; Tal D
    Aerosp Med Hum Perform; 2020 Apr; 91(4):313-317. PubMed ID: 32493552
    [No Abstract]   [Full Text] [Related]  

  • 11. INM investigations into drugs for seasickness prophylaxis.
    Pingree BJ
    J R Nav Med Serv; 1994; 80(2):76-80. PubMed ID: 7707278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of cinnarizine and transdermal scopolamine for the prevention of seasickness in naval crew: a double-blind, randomized, crossover study.
    Gil A; Nachum Z; Tal D; Shupak A
    Clin Neuropharmacol; 2012; 35(1):37-9. PubMed ID: 22139622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Simulator sickness and the
    Cybulski M; Rzeźniczek P; Bilski B
    Med Pr; 2020 Jan; 71(1):47-58. PubMed ID: 31855217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric evaluation of Simulator Sickness Questionnaire and its variants as a measure of cybersickness in consumer virtual environments.
    Sevinc V; Berkman MI
    Appl Ergon; 2020 Jan; 82():102958. PubMed ID: 31563798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous transcutaneous electrical nerve stimulation mitigates simulator sickness symptoms in healthy adults: a crossover study.
    Chu H; Li MH; Huang YC; Lee SY
    BMC Complement Altern Med; 2013 Apr; 13():84. PubMed ID: 23587135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simulator sickness in an army simulator.
    Braithwaite MG; Braithwaite BD
    J Soc Occup Med; 1990; 40(3):105-10. PubMed ID: 2214692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Sea Sickness in Susceptible Flight Crews.
    Powell-Dunford N; Bushby A
    Mil Med; 2017 Nov; 182(11):e1846-e1850. PubMed ID: 29087851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prophylaxis of seasickness. A comparison of cinnarizine with hyoscine.
    Hargreaves J
    Practitioner; 1982 Jan; 226(1363):160. PubMed ID: 7043439
    [No Abstract]   [Full Text] [Related]  

  • 19. Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications.
    Nachum Z; Shupak A; Gordon CR
    Clin Pharmacokinet; 2006; 45(6):543-66. PubMed ID: 16719539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating objective (EEG) and subjective (SSQ) cybersickness in people with susceptibility to motion sickness.
    Jang KM; Kwon M; Nam SG; Kim D; Lim HK
    Appl Ergon; 2022 Jul; 102():103731. PubMed ID: 35248910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.